Holding IMMD can be painful ;) Though I'm quite positive for it in general, I sell some stocks when it jumps too high imo and buy it back around 0.20-.25.. Right now, i'm somewhat concerned that they try too juggle too many balls at once. IMMD barely started direct marketing with Inate and around six months later, it is a proven marketing engine and they are direct-to-customer sales experts..? Yeah, right.
I'd rather see IMMD invest in further studies to prove that beta glucan offer a unique product for wound care and a broader product portfolio for skincare (sun lotion, body milk, product line for men and stuff alike) than exotic products without any IMMD ingredient.
But let's see how revenue and costs develop over the next quarters. That should offer more insight in how the current strategy works.
